Cross-reactive immune responses as primary drivers of malaria chronicity

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 140-151

  Klein, Eili Y ^a,b,c   Graham, Andrea L ^a   Llinás, Manuel ^a,d   Levin, Simon ^a  

^a PRINCETON UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Center for Disease Dynamics Economics and Policy   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE MEMBRANE PROTEIN 1; PARASITE ANTIGEN;

ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; CHRONIC DISEASE; CROSS REACTION; ERYTHROCYTE; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84890832981     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00958-13     Document Type: Article

References (73)

1. Miller LH, Good MF, Milon G. 1994. Malaria pathogenesis. Science 264:1878-1883. http://dx.doi.org/10.1126/science.8009217.
2. Kyes S, Horrocks P, Newbold C. 2001. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55:673-707. http://dx.doi.org/10.1146/annurev.micro.55.1.673.
3. Kraemer SM, Smith JD. 2003. Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family. Mol. Microbiol. 50:1527-1538. http://dx.doi.org/10.1046/j.1365-2958.2003.03814.x.
4. Lavstsen T, Salanti A, Jensen A, Arnot D, Theander T. 2003. Sub-grouping of Plasmodium falciparum3D7var genes basedonsequence analysis of coding and non-coding regions. Malar. J. 2:27. http://dx.doi.org/10.1186/1475-2875-2-27.
5. Scherf A, Hernandez-Rivas R, Buffet P, Bottius E, Benatar C, Pouvelle B, Gysin J, Lanzer M. 1998. Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J. 17: 5418-5426. http://dx.doi.org/10.1093/emboj/17.18.5418.
6. Brannan LR, Turner CMR, Phillips RS. 1994. Malaria parasites undergo antigenic variation at high rates in vivo. Proc. Biol. Sci. 256:71-75. http://dx.doi.org/10.1098/rspb.1994.0051.
7. Kaestli M, Cortes A, Lagog M, Ott M, Beck HP. 2004. Longitudinal assessment of Plasmodium falciparum var gene transcription in naturally infected asymptomatic children in Papua New Guinea. J. Infect. Dis. 189: 1942-1951. http://dx.doi.org/10.1086/383250.
8. Handunnetti SM, Mendis KN, David PH. 1987. Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types. J. Exp. Med. 165:1269-1283.
9. Krause DR, Gatton ML, Frankland S, Eisen DP, Good MF, Tilley L, Cheng Q. 2007. Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers. Infect. Immun. 75:5967-5973. http://dx.doi.org/10.1128/IAI.00327-07.
10. Staalsoe T, Megnekou R, Fievét N, Ricke C, Zornig H, Leke R, Taylor D, Deloron P, Hviid L. 2001. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. J. Infect. Dis. 184:618-626. http://dx.doi.org/10.1086/322809.
11. Chookajorn T, Ponsuwanna P, Cui L. 2008. Mutually exclusive var gene expression in the malaria parasite: multiple layers of regulation. Trends Parasitol. 24:455-461. http://dx.doi.org/10.1016/j.pt.2008.07.005.
12. Scherf A, Lopez-Rubio JJ, Riviere L. 2008. Antigenic variation in Plasmodium falciparum. Annu. Rev. Microbiol. 62:445-470. http://dx.doi.org/10.1146/annurev.micro.61.080706.093134.
13. Paget-McNicol S, Gatton M, Hastings I, Saul A. 2002. The Plasmodium falciparum var gene switching rate, switching mechanism and patterns of parasite recrudescence described by mathematical modelling. Parasitology 124:225-235. http://dx.doi.org/10.1017/S0031182001001160.
14. Horrocks P, Pinches R, Christodoulou Z, Kyes SA, Newbold CI. 2004. Variable var transition rates underlie antigenic variation in malaria. Proc. Natl. Acad. Sci. U.S.A. 101:11129-11134. http://dx.doi.org/10.1073/pnas.0402347101.
15. Molineaux L, Diebner H, Eichner M, Collins W, Jeffery G, Dietz K. 2001. Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology 122:379-391. http://dx.doi.org/10.1017/S0031182001007533.
16. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NPJ. 2005. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2:e204. http://dx.doi.org/10.1371/journal.pmed.0020204.
17. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467. http://dx.doi.org/10.1056/NEJMoa0808859.
18. Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, Newbold C, Gupta S. 2004. Transient cross-reactive immune responses can orchestrate antigenic variation in malaria. Nature 429:555-558. http://dx.doi.org/10.1038/nature02486.
19. Nara PL, Tobin GJ, Chaudhuri AR, Trujillo JD, Lin G, Cho MW, Levin SA, Ndifon W, Wingreen NS. 2010. How can vaccines against influenza and other viral diseases be made more effective? PLoS Biol. 8:e1000571. http://dx.doi.org/10.1371/journal.pbio.1000571.
20. Väkeväinen M, Eklund C, Eskola J, Käyhty H. 2001. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae evoked by pneumococcal conjugate vaccines, in infants. J. Infect. Dis. 184:789-793. http://dx.doi.org/10.1086/322984.
21. Fitzsimmons CM, Jones FM, Pinot de Moira A, Protasio AV, Khalife J, Dickinson HA, Tukahebwa EM, Dunne DW. 2012. Progressive crossreactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis? Infect. Immun. 80:4264-4270. http://dx.doi.org/10.1128/IAI.00641-12.
22. Molineaux L, Dietz K. 1999. Review of intra-host models of malaria. Parassitologia 41:221-231.
23. Sasaki A. 1994. Evolution of antigen drift/switching: continuously evading pathogens. J. Theor. Biol. 168:291-308.
24. Reilly HB, Wang H, Steuter JA, Marx AM, Ferdig MT. 2007. Quantitative dissection of clone-specific growth rates in cultured malaria parasites. Int. J. Parasitol. 37:1599-1607. http://dx.doi.org/10.1016/j.ijpara.2007.05.003.
25. Haydon DT, Matthews L, Timms R, Colegrave N. 2003. Top-down or bottom-up regulation of intra-host blood-stage malaria: do malaria parasites most resemble the dynamics of prey or predator? Proc. R. Soc. London B 270:289-298. http://dx.doi.org/10.1098/rspb.2002.2203.
26. Miller MR, Råberg L, Read AF, Savill NJ. 2010. Quantitative analysis of immune response and erythropoiesis during rodent malarial infection. PLoS Comput. Biol. 6:e1000946. http://dx.doi.org/10.1371/journal.pcbi.1000946.
27. Mideo N, Barclay VC, Chan BHK, Savill NJ, Read AF, Day T. 2008. Understanding and predicting strain-specific patterns of pathogenesis in the rodent malaria Plasmodium chabaudi. Am. Nat. 172:E214-E238. http://dx.doi.org/10.1086/591684.
28. Bejon P, Andrews L, Andersen RF, Dunachie S, Webster D, Walther M, Gilbert SC, Peto T, Hill AVS. 2005. Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J. Infect. Dis. 191:619-626. http://dx.doi.org/10.1086/427243.
29. Cheng Q, Lawrence G, Reed C, Stowers A, Ranford-Cartwright L, Creasey A, Carter R, Saul A. 1997. Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am. J. Trop. Med. Hyg. 57:495-500.
30. Kwiatkowski D, Nowak M. 1991. Periodic and chaotic host-parasite interactions in human malaria. Proc. Natl. Acad. Sci. U.S.A. 88:5111-5113. http://dx.doi.org/10.1073/pnas.88.12.5111.
31. Bruce M, Donnelly C, Alpers M, Galinski M, Barnwell J, Walliker D, Day K. 2000. Cross-species interactions between malaria parasites in humans. Science 287:845. http://dx.doi.org/10.1126/science.287.5454.845.
32. Gravenor MB, McLean AR, Kwiatkowski D. 1995. The regulation of malaria parasitaemia: parameter estimates for a population model. Parasitology 110:115-122. http://dx.doi.org/10.1017/S0031182000063861.
33. Su Z, Stevenson MM. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168:1348-1355.
34. Stevenson MM, Riley EM. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169-180. http://dx.doi.org/10.1038/nri1311.
35. Fearon DT, Locksley RM. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-54. http://dx.doi.org/10.1126/science.272.5258.50.
36. Struik SS, Riley EM. 2004. Does malaria suffer from lack of memory? Immunol. Rev. 201:268-290. http://dx.doi.org/10.1111/j.0105-2896.2004.00181.x.
37. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104702.
38. Smalley ME, Sinden RE. 1977. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 74:1-8. http://dx.doi.org/10.1017/S0031182000047478.
39. Ofori MF, Dodoo D, Staalsoe T, Kurtzhals JAL, Koram K, Theander TG, Akanmori BD, Hviid L. 2002. Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect. Immun.70:2982-2988. http://dx.doi.org/10.1128/IAI.70.6.2982-2988.2002.
40. Bull PC, Lowe BS, Kaleli N, Njuga F, Kortok M, Ross A, Ndungu F, Snow RW, Marsh K. 2002. Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children. J. Infect. Dis. 185:1688-1691. http://dx.doi.org/10.1086/340420.
41. Turner L, Wang CW, Lavstsen T, Mwakalinga SB, Sauerwein RW, Hermsen CC, Theander TG. 2011. Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparummalaria infections in naïve volunteers. PLoS One 6:e29025. http://dx.doi.org/10.1371/journal.pone.0029025.
42. Cortés A, Carret C, Kaneko O, Yim Lim BYS, Ivens A, Holder AA. 2007. Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion. PLoS Pathog. 3:e107. http://dx.doi.org/10.1371/journal.ppat.0030107.
43. Smith JD, Gamain B, Baruch DI, Kyes S. 2001. Decoding the language of var genes and Plasmodium falciparum sequestration. Trends Parasitol. 17: 538-545. http://dx.doi.org/10.1016/S1471-4922(01)02079-7.
44. Kraemer S, Kyes S, Aggarwal G, Springer A, Nelson S, Christodoulou Z, Smith L, Wang W, Levin E, Newbold C, Myler P, Smith J. 2007. Patterns of gene recombination shape var gene repertoires in Plasmodium falciparum: comparisons of geographically diverse isolates.BMCGenomics 8:45. http://dx.doi.org/10.1186/1471-2164-8-45.
45. Rask TS, Hansen DA, Theander TG, Gorm Pedersen A, Lavstsen T. 2010. Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes-divide and conquer. PLoS Comput. Biol. 6:e1000933. http://dx.doi.org/10.1371/journal.pcbi.1000933.
46. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948. http://dx.doi.org/10.1093/bioinformatics/btm404.
47. Eyles DE, Young MD. 1951. The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host. J. Natl. Malar. Soc. 10:327-336.
48. Szmitko PE, Kohn ML, Simor AE. 2009. Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagn. Microbiol. Infect. Dis. 63:105-107. http://dx.doi.org/10.1016/j.diagmicrobio.2008.08.017.
49. Bachmann A, Predehl S, May J, Harder S, Burchard GD, Gilberger T-W, Tannich E, Bruchhaus I. 2011. Highly co-ordinated var gene expression and switching in clinical Plasmodium falciparum isolates from non-immune malaria patients. Cell Microbiol. 13:1397-1409. http://dx.doi.org/10.1111/j.1462-5822.2011.01629.x.
50. Recker M, Buckee CO, Serazin A, Kyes S, Pinches R, Christodoulou Z, Springer AL, Gupta S, Newbold CI. 2011. Antigenic variation in Plasmodium falciparum malaria involves a highly structured switching pattern. PLoS Pathog. 7:e1001306. http://dx.doi.org/10.1371/journal.ppat.1001306.
51. Bruce MC, Donnelly CA, Packer M, Lagog M, Gibson N, Narara A, Walliker D, Alpers MP, Day KP. 2000. Age-and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitology 121:247-256. http://dx.doi.org/10.1017/S0031182099006344.
52. Tran TM, Li S, Doumbo S, Doumtabe D, Huang C-Y, Dia S, Bathily A, Sangala J, Kone Y, Traore A, Niangaly M, Dara C, Kayentao K, Ongoiba A, Doumbo OK, Traore B, Crompton PD. 2013. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin. Infect. Dis. 57:40-47. http://dx.doi.org/10.1093/cid/cit174.
53. Collins WE, Jeffery GM. 1999. A retrospective examination of secondary sporozoite-and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am. J. Trop. Med. Hyg. 61:20-35.
54. McKenzie FE, Bossert WH. 2005. An integrated model of Plasmodium falciparum dynamics. J. Theor. Biol. 232:411-426. http://dx.doi.org/10.1016/j.jtbi.2004.08.021.
55. Wang CW, Hermsen CC, Sauerwein RW, Arnot DE, Theander TG, Lavstsen T. 2009. The Plasmodium falciparum var gene transcription strategy at the onset of blood stage infection in a human volunteer. Parasitol. Int. 58:478-480. http://dx.doi.org/10.1016/j.parint.2009.07.004.
56. Johnston GL, Smith DL, Fidock DA. 2013. Malaria's missing number: calculating the human component of R0 by a within-host mechanistic model of Plasmodium falciparum infection and transmission. PLoS Comput. Biol. 9:e1003025. http://dx.doi.org/10.1371/journal.pcbi.1003025.
57. Johnson PL, Kochin BF, Ahmed R, Antia R. 2012. How do antigenically varying pathogens avoid cross-reactive responses to invariant antigens? Proc. R. Soc. B Biol. Sci. 279:2777-2785. http://dx.doi.org/10.1098/rspb.2012.0005.
58. Freeman GJ, Sharpe AH. 2012. A new therapeutic strategy for malaria: targeting T cell exhaustion. Nat. Immunol. 13:113-115. http://dx.doi.org/10.1038/ni.2211.
59. Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, Waldschmidt TJ, Crompton PD, Harty JT. 2012. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 13:188-195. http://dx.doi.org/10.1038/ni.2180.
60. Jensen A, Magistrado P, Sharp S, Joergensen L, Lavstsen T, Chiucchiuini A, Salanti A, Vestergaard L, Lusingu J, Hermsen R. 2004. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J. Exp. Med. 199:1179-1190. http://dx.doi.org/10.1084/jem.20040274.
61. Rottmann M, Lavstsen T, Mugasa JP, Kaestli M, Jensen ATR, Muller D, Theander T, Beck H-P. 2006. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect. Immun. 74:3904-3911. http://dx.doi.org/10.1128/IAI.02073-05.
62. Lavstsen T, Turner L, Saguti F, Magistrado P, Rask TS, Jespersen JS, Wang CW, Berger SS, Baraka V, Marquard AM, Seguin-Orlando A, Willerslev E, Gilbert MTP, Lusingu J, Theander TG. 2012. Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children. Proc. Natl. Acad. Sci. U.S.A.n 109:E1791-E1800. http://dx.doi.org/10.1073/pnas.1120455109.
63. Avril M, Tripathi AK, Brazier AJ, Andisi C, Janes JH, Soma VL, Sullivan DJ, Bull PC, Stins MF, Smith JD. 2012. A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 109:E1782-E1790. http://dx.doi.org/10.1073/pnas.1120534109.
64. Claessens A, Adams Y, Ghumra A, Lindergard G, Buchan CC, Andisi C, Bull PC, Mok S, Gupta AP, Wang CW, Turner L, Arman M, Raza A, Bozdech Z, Rowe JA. 2012. A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 109:E1772-E1781. http://dx.doi.org/10.1073/pnas.1120461109.
65. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. 2006. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22:503-508. http://dx.doi.org/10.1016/j.pt.2006.09.002.
66. Chen DS, Barry AE, Leliwa-Sytek A, Smith T-A, Peterson I, Brown SM, Migot-Nabias F, Deloron P, Kortok MM, Marsh K, Daily JP, Ndiaye D, Sarr O, Mboup S, Day KP. 2011. A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa. PLoS One 6:e16629. http://dx.doi.org/10.1371/journal.pone.0016629.
67. Cham G, Turner L, Lusingu J, Vestergaard L, Mmbando B, Kurtis J, Jensen A, Salanti A, Lavstsen T, Theander T. 2009. Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains. J. Immunol. 183:3356-3363. http://dx.doi.org/10.4049/jimmunol.0901331.
68. Chotivanich K, Udomsangpetch R, Simpson JA, Newton P, Pukrittayakamee S, Looareesuwan S, White NJ. 2000. Parasite multiplication potential and the severity of falciparum malaria. J. Infect. Dis. 181:1206-1209. http://dx.doi.org/10.1086/315353.
69. Nassir E, Abdel-Muhsin A-MA, Suliaman S, Kenyon F, Kheir A, Geha H, Ferguson HM, Walliker D, Babiker HA. 2005. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int. J. Parasitol. 35:49-55. http://dx.doi.org/10.1016/j.ijpara.2004.10.014.
70. Antia R, Bergstrom CT, Pilyugin SS, Kaech SM, Ahmed R. 2003. Models of CD8+ responses: 1. What is the antigen-independent proliferation program. J. Theor. Biol. 221:585-598. http://dx.doi.org/10.1006/jtbi.2003.3208.
71. Klein MM, Gittis AG, Su H-P, Makobongo MO, Moore JM, Singh S, Miller LH, Garboczi DN. 2008. The cysteine-rich interdomain region from the highly variable Plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure. PLoS Pathog. 4:e1000147. http://dx.doi.org/10.1371/journal.ppat.1000147.
72. Bull P, Berriman M, Kyes S, Quail M, Hall N, Kortok M, Marsh K, Newbold C. 2005. Plasmodium falciparum variant surface antigen expression patterns during malaria. PLoS Pathog. 1:e26. http://dx.doi.org/10.1371/journal.ppat.0010026.
73. Graham AL. 2008. Ecological rules governing helminth-microparasite coinfection. Proc. Natl. Acad. Sci. U.S.A. 105:566-570. http://dx.doi.org/10.1073/pnas.0707221105.